Atenolol for the Prevention of Osteoporosis (APO)

NCT04905277 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

420

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Atenolol 50 MG
DRUG: Placebo

Sponsor

Sundeep Khosla, M.D.

Collaborators

[object Object]
[object Object]
[object Object]